| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Patent filing fees | 34 | 13 |
| Net cash provided by investing activities | 12,441 | 17,782 |
| Proceeds from private placement of common stock | 14,792 | - |
| Issuance costs associated with private placement | 1,058 | - |
| Proceeds from exercise of stock options | 406 | 374 |
| Employee stock purchase plan ('espp') purchases | 548 | 548 |
| Net cash provided by financing activities | 14,688 | 922 |
| Net increase (decrease) in cash and cash equivalents | 1,372 | -1,834 |
| Cash and cash equivalents at beginning of period | 14,050 | - |
| Cash and cash equivalents at end of period | 15,422 | - |
AVITA Medical, Inc. (AVHHL)
AVITA Medical, Inc. (AVHHL)